低外径覆膜支架在钝性创伤性主动脉损伤中的早期生存获益
这项前瞻性多中心研究评估RelayPro胸主动脉覆膜支架治疗钝性创伤性主动脉损伤的安全性和有效性,2017至2021年在美国16个中心入组50例患者。30天全因死亡率为2%,低于预设性能目标上限25%,Kaplan-Meier估计30天至4年免于全因死亡率为98%。作者认为RelayPro安全有效,可能提供早期生存获益。
要点
- 50例钝性创伤性主动脉损伤患者在美国16个中心接受RelayPro胸主动脉覆膜支架治疗,技术成功率98%。
- 30天全因死亡率为2%,精确双侧95%CI为0.1%至10.6%,低于性能目标上限25%。
- Kaplan-Meier估计30天至4年免于全因死亡率为98%(95%CI 86.6%-99.7%)。
核心结论
- 作者认为RelayPro安全有效,可能在钝性创伤性主动脉损伤治疗中提供早期生存获益。
研究设计与样本
- 前瞻性多中心研究,评估RelayPro胸主动脉覆膜支架治疗创伤性主动脉损伤,2017至2021年在美国16个中心入组50例患者。
- 主要终点为30天全因死亡率。
主要发现
- 队列以男性为主(74%),平均年龄42.4±17.2岁,损伤原因以机动车碰撞为主(80%),损伤分级为1级4%、2级8%、3级76%、4级12%。
- 近端锚定区位于左锁骨下动脉近端的占42%,入路主要为经皮(80%),71%使用非裸支架覆膜支架。
- 技术成功率为98%(1例早期Ia型内漏);30天全因死亡率为2%,预期率为8%,精确双侧95%CI为0.1%至10.6%,低于性能目标上限25%。
- Kaplan-Meier估计30天至4年免于全因死亡率为98%(95%CI 86.6%-99.7%);免于主要不良事件、全因死亡、截瘫和卒中的Kaplan-Meier估计在30天为98.0%,6个月至4年为95.8%(95%CI 84.3%-98.9%)。
- 随访期间无卒中发生,截瘫1例(2%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to demonstrate the safety and effectiveness of a low-profile thoracic endograft (19-23 French) in subjects with blunt traumatic aortic injury. METHODS: A prospective, multicenter study assessed the RelayPro thoracic endograft for the treatment of traumatic aortic injury. Fifty patients were enrolled at 16 centers in the United States between 2017 and 2021. The primary endpoint was 30-day all-cause mortality. RESULTS: The cohort was mostly male (74%), with a mean age of 42.4 ± 17.2 years, and treated for traumatic injuries (4% Grade 1, 8% Grade 2, 76% Grade 3, and 12% Grade 4) due to motor vehicle collision (80%). The proximal landing zone was proximal to the left subclavian artery in 42%, and access was primarily percutaneous (80%). Most (71%) were treated with a non-bare stent endograft. Technical success was 98% (one early type Ia endoleak). All-cause 30-day mortality was 2% (compared with an expected rate of 8%), with an exact two-sided 95% confidence interval [CI] of 0.1%, 10.6% below the performance goal upper limit of 25%. Kaplan-Meier analysis estimated freedom from all-cause mortality to be 98% at 30 days through 4 years (95% CI, 86.6%-99.7%). Kaplan-Meier estimated freedom from major adverse events, all-cause mortality, paralysis, and stroke, was 98.0% at 30 days and 95.8% from 6 months to 4 years (95% CI, 84.3%-98.9%). There were no strokes and one case of paraplegia (2%) during follow-up. CONCLUSIONS: RelayPro was safe and effective and may provide an early survival benefit in the treatment of blunt traumatic aortic injury.
引用
- Starnes BW, Rajani RR, Rossi P, et al. Early survival benefit of a low-profile endograft in blunt traumatic aortic injury. J Vasc Surg. 2024. PMID: 38677660. doi:10.1016/j.jvs.2024.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。